
DRS.LINQ is redefining cardiac care with mHeart, a first-of-its-kind mobile platform that combines a self-administered 10-lead multiparametric EKG device with a robust remote management system. Designed by cardiologists for cardiologists and patients, mHeart enables rapid triage, biweekly monitoring, and long-term cardiac management — improving outcomes, reducing healthcare costs, and empowering patients through early intervention and real-time physician connectivity.
Lead Program & Pipeline
-
Lead product: mHeart — a mobile EKG-enabled care platform for acute and chronic cardiac management
-
Includes 10-lead self-administered EKG and a remote management interface
-
Aims to reduce ER visits, hospital readmissions, and cardiac-related mortality
-
Targeting use in post-operative care, chronic condition monitoring, and chest pain triage
-
Future pipeline includes predictive AI/ML algorithms for risk stratification and personalized care
Technology Differentiators
-
Combines FDA-cleared 10-lead EKG hardware with remote software platform
-
Enables patient-initiated triage within 15 minutes of symptom onset
-
Supports physicians with reimbursable telehealth services and real-time cardiac data
-
Collects biweekly EKGs to build a longitudinal cardiac profile
-
Designed to reduce unnecessary ER visits and improve heart failure, AFib, and ACS outcomes
Stage & Investment
-
Stage: Product development (Gen 1 hardware & software in progress)
-
Funding Raised: <$500K
-
IP: Utility patent in process; design patents filed (US, Canada, EU); future patents for software/AI planned
-
Regulatory: 510(k) path confirmed by FDA for hardware; SaMD submission planned post-data collection
-
Collaborations: LOI in progress with Atrial Health; early discussions with Cleveland Clinic, Capital Health, and Mount Sinai
What's Next
-
Complete Gen 1 software (6 months) and hardware (12 months)
-
Conduct clinical data collection and submit for 510(k) (12–14 months)
-
Achieve FDA clearance (16–18 months)
-
Expand team, customer outreach, and prepare for manufacturing and commercialization
-
Secure funding and strategic partners to position mHeart as a category-defining digital health platform